4.3 Article

Minocycline, but not doxycycline attenuates NMDA-induced [Ca2+]i and excitotoxicity

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

Mechanism of NMDA receptor channel block by MK-801 and memantine

Xianqiang Song et al.

NATURE (2018)

Article Medicine, Research & Experimental

Glutamatergic Mechanisms Associated with Seizures and Epilepsy

Melissa Barker-Haliski et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)

Review Neurosciences

NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease

Pierre Paoletti et al.

NATURE REVIEWS NEUROSCIENCE (2013)

Review Behavioral Sciences

The NMDA receptor complex as a therapeutic target in epilepsy: a review

Mehdi Ghasemi et al.

EPILEPSY & BEHAVIOR (2011)

Article Biochemistry & Molecular Biology

Testing the Therapeutic Potential of Doxycycline in a Drosophila melanogaster Model of Alzheimer Disease

Rita Costa et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2011)

Article Behavioral Sciences

Doxycycline protects against pilocarpine-induced convulsions in rats, through its antioxidant effect and modulation of brain amino acids

Carlos Renato Alves Nogueira et al.

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2011)

Article Neurosciences

Copper transport to the brain by the blood-brain barrier and blood-CSF barrier

Byuny-Sun Choi et al.

BRAIN RESEARCH (2009)

Article Clinical Neurology

Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury

KL Arvin et al.

ANNALS OF NEUROLOGY (2002)

Article Multidisciplinary Sciences

Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease

YS Du et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)

Article Pharmacology & Pharmacy

SB-334867-A: the first selective orexin-1 receptor antagonist

D Smart et al.

BRITISH JOURNAL OF PHARMACOLOGY (2001)